Dermatological Side Effects Rarely Interfere With the Continuation of Checkpoint Inhibitor Immunotherapy for Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
International Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dermatological Side Effects Rarely Interfere With the Continuation of Checkpoint Inhibitor Immunotherapy for Cancer
Int. J. Dermatol 2020 Sep 08;[EPub Ahead of Print], JFJ Rovers, HJ BovenschenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.